Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253682 · ClinicalTrials.gov registry record
Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers
A clinical trial of HIV Infections and Cardiovascular Diseases, sponsored by University of Miami.
- Completed
- Registry status
- 167
- Enrollment target
- 5
- Study locations
NCT00253682: Completed study of HIV Infections and Cardiovascular Diseases, sponsored by University of Miami.
NCT00253682 is a study of HIV Infections and Cardiovascular Diseases that has completed, run by University of Miami. The registered enrollment target is 167 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00253682, a study of HIV Infections and Cardiovascular Diseases, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.
Conditions Studied
Study Locations (5)
Florida
- University of Miami School of Medicine - Miami
Illinois
- University of Illinois - Chicago - Chicago
Massachusetts
- Boston Medical Center - Boston
New York
- Columbia University - New York
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2002-09 |
| Est. Completion | 2006-12 |
What the finished NCT00253682 record still lists
NCT00253682 is an observational study that tracks outcomes without assigning an intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower).
The record links to 5 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00253682 lists 5 locations in 5 states (Florida, Illinois, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00253682 about?
NCT00253682 is a clinical study titled "Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers". This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.
What is the current status of trial NCT00253682?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2002-09. Estimated completion is 2006-12.
What conditions does trial NCT00253682 study?
This clinical trial studies the following conditions: HIV Infections, Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Cardiomyopathy, Hypertrophic.
Who is sponsoring clinical trial NCT00253682?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00253682 being conducted?
This trial has 5 study locations across Florida, Illinois, Massachusetts, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00253682's enrollment target sits among peer trials
167 200th of 542 higher than 343 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia